238 related articles for article (PubMed ID: 6430791)
21. Interaction of desialated guinea pig erythrocytes with the classical and alternative pathways of guinea pig complement in vivo and in vitro.
Brown EJ; Joiner KA; Frank MM
J Clin Invest; 1983 Jun; 71(6):1710-9. PubMed ID: 6863540
[TBL] [Abstract][Full Text] [Related]
22. Serum haemolytic complement activities in 11 different MHC (B) typed chicken lines.
Parmentier HK; Baelmans R; Savelkoul HF; Dorny P; Demey F; Berkvens D
Vet Immunol Immunopathol; 2004 Jul; 100(1-2):25-32. PubMed ID: 15182993
[TBL] [Abstract][Full Text] [Related]
23. Activation of the human classical complement pathway by a mouse monoclonal hybrid IgG1-2a monovalent anti-TNP antibody bound to TNP-conjugated cells.
Couderc J; Kazatchkine MD; Ventura M; Duc HT; Maillet F; Thobie N; Liacopoulos P
J Immunol; 1985 Jan; 134(1):486-91. PubMed ID: 3917282
[TBL] [Abstract][Full Text] [Related]
24. Deviated lysis: lysis of unsensitized cells by complement. V. Generation of the activity of low pH or low ionic strength.
Rother U; Hänsch G; Rauterberg EW; Jungfer H; Rother K
Z Immunitatsforsch Immunobiol; 1978 Dec; 155(2):118-29. PubMed ID: 34275
[TBL] [Abstract][Full Text] [Related]
25. [Threshold mechanism of the control of cascade proteolysis].
Shcherbak IG
Bioorg Khim; 1998 May; 24(5):364-9. PubMed ID: 9661790
[TBL] [Abstract][Full Text] [Related]
26. Binding of C-reactive protein to nucleated cells leads to complement activation without cytolysis.
Berman S; Gewurz H; Mold C
J Immunol; 1986 Feb; 136(4):1354-9. PubMed ID: 3944459
[TBL] [Abstract][Full Text] [Related]
27. Kinetic assessment of alternative complement pathway activity in a hemolytic system. II. Influence of antibody on alternative pathway activation.
Polhill RB; Newman SL; Pruitt KM; Johnston RB
J Immunol; 1978 Jul; 121(1):371-6. PubMed ID: 670706
[TBL] [Abstract][Full Text] [Related]
28. Ability to activate the alternative complement pathway acquired by human and guinea-pig erythrocytes after contact with influenza virus.
Lambré C; Thibon M
Ann Immunol (Paris); 1980; 131C(2):213-21. PubMed ID: 7416718
[TBL] [Abstract][Full Text] [Related]
29. Activation of the alternative pathway of human complement by haemoglobin.
Wilson WA; Thomas EJ
Clin Exp Immunol; 1979 Apr; 36(1):140-4. PubMed ID: 111881
[TBL] [Abstract][Full Text] [Related]
30. Complement activating property of the protein-rich endotoxin (OEP) of Pseudomonas aeruginosa. I. Activation of both the classical and the alternative pathways of guinea pig complement.
Inada K
Jpn J Exp Med; 1980 Feb; 50(1):13-21. PubMed ID: 6770130
[TBL] [Abstract][Full Text] [Related]
31. Alternate complement pathway activation by recluse spider venom.
Kurpiewski G; Campbell BJ; Forrester LJ; Barrett JT
Int J Tissue React; 1981 Mar; 3(1):39-45. PubMed ID: 7287056
[TBL] [Abstract][Full Text] [Related]
32. Alternative complement pathway-dependent ingestion of fluolite particles by human granulocytes.
Arnaout MA; Luscinskas FW; Lionetti FJ; Alper CA; Valeri CR
J Immunol; 1981 Jul; 127(1):278-81. PubMed ID: 6787126
[TBL] [Abstract][Full Text] [Related]
33. [Concentration-functional interrelationships in the human alternative complement activation pathway].
Galebskaia LV; Shcherbak IG; Bel'tiukov PP; Riumina EV; Solovtsova IL
Biokhimiia; 1993 Nov; 58(11):1796-800. PubMed ID: 8268316
[TBL] [Abstract][Full Text] [Related]
34. Lysis of alloantibody-sensitized human erythrocytes by peripheral blood mononuclear cells: heterogeneity of effector populations.
Kimber I; Moore M
J Clin Lab Immunol; 1981 Jan; 5(1):41-6. PubMed ID: 6260947
[TBL] [Abstract][Full Text] [Related]
35. Neutralization of influenza virus by normal human sera: mechanisms involving antibody and complement.
Beebe DP; Schreiber RD; Cooper NR
J Immunol; 1983 Mar; 130(3):1317-22. PubMed ID: 6822737
[TBL] [Abstract][Full Text] [Related]
36. Role of divalent metal ions in serum complement activity of the American alligator (Alligator mississippiensis).
Merchant ME; Verret B; Elsey RM
Comp Biochem Physiol B Biochem Mol Biol; 2005 Jul; 141(3):289-93. PubMed ID: 15922642
[TBL] [Abstract][Full Text] [Related]
37. Differential susceptibility of haemolysin-sensitized erythrocytes to complement-mediated cytotoxicity: a biological manifestation of the relationship between antibody availability and complement fixation.
Bakács T; Ringwald G; Kimber I
J Clin Lab Immunol; 1989 Oct; 30(2):61-7. PubMed ID: 2641530
[TBL] [Abstract][Full Text] [Related]
38. Heterotoxicity of human serum. IV. Role of the alternative complement pathway and natural antibody in the lethal toxicity of human serum for mice.
Rozenfarb E; Eidinger D
Int Arch Allergy Appl Immunol; 1979; 60(4):414-26. PubMed ID: 500231
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms of complement activation and effects of C1-inhibitor on the meconium-induced inflammatory reaction in human cord blood.
Salvesen B; Nielsen EW; Harboe M; Saugstad OD; Mollnes TE
Mol Immunol; 2009 Feb; 46(4):688-94. PubMed ID: 18950866
[TBL] [Abstract][Full Text] [Related]
40. Identification and characterization of serum complement activity in the American crocodile (Crocodylus acutus).
Merchant M; McFatter J; Mead S; McAdon C; Wasilewski J
Vet Immunol Immunopathol; 2010 Feb; 133(2-4):165-9. PubMed ID: 19716182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
